| 2-(CYCLOHEXYLAMINO)-5-NITRO-N-[(PENTYLAMINO)CARBONYL]-BENZENESULFONAMIDE |
2-(CYCLOHEXYLAMINO)-5-NITRO-N-[(PENTYLAMINO)CARBONYL]-BENZENESULFONAMIDE |
284464-77-3 |
| GW7647 |
2-[[4-[2-[[环己基氨基)羰基](4-环己基丁基)氨基]乙基]苯基]硫基]-2-甲基丙酸 |
265129-71-3 |
| 1-Benzoyl-2-[[trans-4-[[[[2-nitro-4-(trifluoromethyl)phenyl]sulfonyl]amino]methyl]cyclohexyl]carbonyl]hydrazine |
1-Benzoyl-2-[[trans-4-[[[[2-nitro-4-(trifluoromethyl)phenyl]sulfonyl]amino]methyl]cyclohexyl]carbonyl]hydrazine |
263849-50-9 |
| MS 245 oxalate |
MS 245 OXALATE |
263384-65-2 |
| L-gamma-Glutamyl-S-(phenylmethyl)-L-cysteinyl-2-phenylglycine diethyl ester monohydrochloride |
L-GAMMA-谷氨酰基-S-苄基-L-半胱氨酰基-2-苯基甘氨酸二乙酯盐酸盐 |
286942-97-0 |
| N(L-TYROSINE)-9Z,12Z,15Z-OCTADECATRIENAMIDE |
N(L-TYROSINE)-9Z,12Z,15Z-OCTADECATRIENAMIDE |
259143-19-6 |
| GHRELIN (HUMAN) |
来诺瑞林 |
258279-04-8 |
| SE 175 |
SE 175 |
258278-64-7 |
| valiphenal |
霜霉灭 |
283159-90-0 |
| THYROID HORMONE RECEPTOR ANTAGONIST, 1-850 |
THYROID HORMONE RECEPTOR ANTAGONIST, 1-850 |
251310-57-3 |
| SU 16f |
化合物 T16947 |
251356-45-3 |
| D15 |
D15 |
251939-41-0 |
| (AR)-A-CYCLOPENTYL-A-HYDROXY-N-[1-(4-METHYL-3-PENTENYL)-4-PIPERIDINYL]BENZENEACETAMIDE FUMARATE |
(AR)-A-CYCLOPENTYL-A-HYDROXY-N-[1-(4-METHYL-3-PENTENYL)-4-PIPERIDINYL]BENZENEACETAMIDE FUMARATE |
244277-89-2 |
| MB-05032 |
2-氨基-5-异丁基-4-[5-膦酰基-2-呋喃基]噻唑 |
261365-11-1 |
| MIV-150 |
MIV-150 |
231957-54-3 |
| AGN 194310 |
CS-1211 |
229961-45-9 |
| (R)-3-((S)-1-((S)-2-methoxy-1-phenylethylamino)-3,3-dimethyl-1-oxobutan-2-ylcarbamoyl)-6-(2-methylbiphenyl-4-yl)hexanoic acid |
(R)-3-((S)-1-((S)-2-methoxy-1-phenylethylamino)-3,3-dimethyl-1-oxobutan-2-ylcarbamoyl)-6-(2-methylbiphenyl-4-yl)hexanoic acid |
230961-21-4 |
| LB 42708 |
2MG |
226929-39-1 |
| 8-Hydroxypyrene-1,3,6-tris-sulfonicacid-8-1-(2-nitrophenyl)ethylether |
8-Hydroxypyrene-1,3,6-tris-sulfonicacid-8-1-(2-nitrophenyl)ethylether |
223759-19-1 |
| N-Ethyl-7,10-dihydro-8-nitro-7-oxo-N-propyl-1,10-phenanthroline-3-carboxamide |
N-乙基-7,10-二氢-8-硝基-7-氧代-N-乙基-1,10-菲罗啉-3-甲酰胺 |
223666-07-7 |
